+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cephamandole"

Global and Chinese Cefamandole Nafate Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Cefamandole Nafate Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 141 Pages
  • China, Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Cephamandole is a class of antibiotics used to treat a variety of bacterial infections. It is a broad-spectrum antibiotic, meaning it is effective against a wide range of bacteria. Cephamandole is often used to treat infections that are resistant to other antibiotics, such as penicillin. It is also used to treat infections caused by Gram-negative bacteria, which are more difficult to treat than Gram-positive bacteria. Cephamandole is available in both oral and intravenous forms. The cephamandole market is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, and Novartis. These companies are constantly innovating and developing new formulations of cephamandole to meet the needs of patients. Additionally, generic versions of cephamandole are also available, allowing patients to access the drug at a lower cost. Show Less Read more